Literature DB >> 23340918

Serum 25-hydroxyvitamin D, parathyroid hormone, and their association with metabolic syndrome in Chinese.

Li-Hua Li1, Xue-Yan Yin, Chao-Yong Yao, Xue-Chuang Zhu, Xin-Hua Wu.   

Abstract

Increasing evidence suggests that 25-hydroxyvitamin D [25(OH)D] and parathyroid hormone (PTH) levels are associated with metabolic syndrome (MetS). In 2010, we explored the association of serum 25(OH)D and PTH levels with MetS in 1,390 Chinese participants, aged 20-83 years. Anthropometric phenotypes, blood pressure, and the incidence of MetS were evaluated. In addition, serum lipids, 25(OH)D, and PTH were measured. The median concentration of 25(OH)D and PTH were 55.3 nmol/l and 2.8 pmol/l, respectively. The prevalence of vitamin D deficiency (<50 nmol/l) was 39.9 %, with 34.5 % in men and 47.8 % in women. After accounting for confounding factors and serum PTH, a 10 nmol/l higher serum 25(OH)D level was associated with a 10 % lower risk of MetS (OR = 0.90, 95 % CI 0.84-0.96, P = 0.0007). Furthermore, participants with vitamin D sufficiency had a 35 % lower risk of MetS than those with vitamin D deficiency (OR = 0.65, 95 % CI 0.51-0.84, P = 0.0009). PTH was not associated with the risk of MetS after adjustment for confounding factors. These results were confirmed in both men and women. Thus in this cohort of Chinese individuals, vitamin D deficiency is common and optimal vitamin D level is inversely associated with MetS, independent of several confounders and PTH level. The clinical significance of these findings warrants further study.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23340918     DOI: 10.1007/s12020-013-9885-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  37 in total

1.  Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population?

Authors:  Núria Vilarrasa; Joan Vendrell; Javier Maravall; Iñaki Elío; Esther Solano; Patricia San José; Isabel García; Núria Virgili; Juan Soler; José Manuel Gómez
Journal:  Endocrine       Date:  2010-07-23       Impact factor: 3.633

2.  Preanalytical stability of 25(OH)-vitamin D3 in human blood or serum at room temperature: solid as a rock.

Authors:  Jos P M Wielders; Ferdinand A Wijnberg
Journal:  Clin Chem       Date:  2009-06-18       Impact factor: 8.327

3.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

4.  Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults.

Authors:  Jared P Reis; Denise von Mühlen; Donna Kritz-Silverstein; Deborah L Wingard; Elizabeth Barrett-Connor
Journal:  Diabetes Care       Date:  2007-03-10       Impact factor: 19.112

5.  Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults.

Authors:  Jared P Reis; Denise von Mühlen; Edgar R Miller
Journal:  Eur J Endocrinol       Date:  2008-04-21       Impact factor: 6.664

6.  Vitamin D, PTH, and the metabolic syndrome in severely obese subjects.

Authors:  Sergio Rueda; Cristian Fernández-Fernández; Fabiola Romero; Jesús Martínez de Osaba; Josep Vidal
Journal:  Obes Surg       Date:  2008-01-04       Impact factor: 4.129

7.  Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers.

Authors:  Armin Zittermann; Sabine Frisch; Heiner K Berthold; Christian Götting; Joachim Kuhn; Knut Kleesiek; Peter Stehle; Heinrich Koertke; Reiner Koerfer
Journal:  Am J Clin Nutr       Date:  2009-03-25       Impact factor: 7.045

8.  Insulin-like growth factor I, growth hormone, and insulin sensitivity: the effects of a one-year cholecalciferol supplementation in middle-aged overweight and obese subjects.

Authors:  Elena Kamycheva; Vivian Berg; Rolf Jorde
Journal:  Endocrine       Date:  2012-10-30       Impact factor: 3.633

9.  Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity.

Authors:  José I Botella-Carretero; Francisco Alvarez-Blasco; Juan J Villafruela; José A Balsa; Clotilde Vázquez; Héctor F Escobar-Morreale
Journal:  Clin Nutr       Date:  2007-07-10       Impact factor: 7.324

10.  Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals.

Authors:  Ling Lu; Zhijie Yu; An Pan; Frank B Hu; Oscar H Franco; Huaixing Li; Xiaoying Li; Xilin Yang; Yan Chen; Xu Lin
Journal:  Diabetes Care       Date:  2009-04-14       Impact factor: 17.152

View more
  13 in total

1.  Increased low-density lipoprotein cholesterol level is associated with non-vertebral fractures in postmenopausal women.

Authors:  Mika Yamauchi; Toru Yamaguchi; Kiyoko Nawata; Ken-ichiro Tanaka; Shin Takaoka; Toshitsugu Sugimoto
Journal:  Endocrine       Date:  2014-05-23       Impact factor: 3.633

2.  Serum N(1)-Methylnicotinamide Is Associated With Obesity and Diabetes in Chinese.

Authors:  Ming Liu; Lihua Li; Jihong Chu; Boyu Zhu; Qingtao Zhang; Xueyan Yin; Weimin Jiang; Guoliang Dai; Wenzheng Ju; Zhenxing Wang; Qin Yang; Zhuyuan Fang
Journal:  J Clin Endocrinol Metab       Date:  2015-06-12       Impact factor: 5.958

3.  The effects of vitamin D supplementation on proatherogenic inflammatory markers and carotid intima media thickness in subjects with metabolic syndrome: a randomized double-blind placebo-controlled clinical trial.

Authors:  Shabnam Salekzamani; Abolhassan Shakeri Bavil; Hossein Mehralizadeh; Mohammad Asghari Jafarabadi; Aymaral Ghezel; Bahram Pourghassem Gargari
Journal:  Endocrine       Date:  2017-05-16       Impact factor: 3.633

4.  Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial.

Authors:  Nasrin Sharifi; Reza Amani; Eskandar Hajiani; Bahman Cheraghian
Journal:  Endocrine       Date:  2014-06-27       Impact factor: 3.633

5.  Low vitamin D status is associated with advanced liver fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Bing-Bing Yang; Yuan-Hua Chen; Cheng Zhang; Chang-E Shi; Kai-Feng Hu; Ju Zhou; De-Xiang Xu; Xi Chen
Journal:  Endocrine       Date:  2016-10-31       Impact factor: 3.633

6.  Investigation of serum bisphenol A, vitamin D, and parathyroid hormone levels in patients with obstructive sleep apnea syndrome.

Authors:  Ersin Sukru Erden; Sebahat Genc; Sedat Motor; Ihsan Ustun; Kemal Turker Ulutas; Hatice Kayim Bilgic; Suleyman Oktar; Sana Sungur; Cihangir Erem; Cumali Gokce
Journal:  Endocrine       Date:  2013-08-01       Impact factor: 3.633

7.  Hypovitaminosis D in adolescents living in the land of sun is correlated with incorrect life style: a survey study in Campania region.

Authors:  Annamaria Colao; Giovanna Muscogiuri; Manila Rubino; Laura Vuolo; Claudia Pivonello; Pasquale Sabatino; Mara Pizzo; Gelsomina Campanile; Rosa Fittipaldi; Gaetano Lombardi; Carolina Di Somma
Journal:  Endocrine       Date:  2014-11-21       Impact factor: 3.633

8.  Carotid intima-media thickness is not associated with vitamin D and PTH levels in patients admitted to an Internal Medicine Department.

Authors:  Vincenzo Carnevale; Rita Minonne; Angela De Matthaeis; Maria Antonietta Annese; Patrizia Tabacco; Palmina D'Arcangelo; Graziella D'Amico; Alfredo Scillitani
Journal:  Endocrine       Date:  2014-02-13       Impact factor: 3.633

9.  Serum levels of 25-hydroxyvitamin D are associated with cognitive impairment in type 2 diabetic adults.

Authors:  Rui-hua Chen; Xiao-hui Zhao; Zhe Gu; Pei-li Gu; Bin Zhou; Zhen-hong Zhu; Lin-yan Xu; Yu-feng Zou; Xiao-zhen Jiang
Journal:  Endocrine       Date:  2013-08-28       Impact factor: 3.633

10.  Association between serum vitamin D, parathyroid hormone and metabolic syndrome in middle-aged and older Korean adults.

Authors:  J Kim
Journal:  Eur J Clin Nutr       Date:  2014-09-24       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.